Back to Journals » Drug Design, Development and Therapy » Volume 14

Clinical Trial Report

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

       
Total article views   HTML views PDF downloads Totals
7,271 Dovepress* 6,125+ 717 6,842
PubMed Central* 1,146 476 1,622
Totals 7,271 1,193 8,464
*Since 8 December 2020

View citations on PubMed Central and Google Scholar